Evidence map›Paper›PMID 31530493›Full record

ArticleJournal of vascular and interventional radiology : JVIR2020

Impact of Renal Function Trajectory on Renal Replacement Therapy and Mortality Risk after Renal Artery Revascularization.

Edwin A Takahashi, William S Harmsen, Sanjay Misra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of vascular and interventional radiology : JVIR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Edwin A TakahashiDepartment of Radiology, Mayo Clinic, Rochester, 200 First St. SW, Rochester, MN 55905; Division of Vascular and Interventional Radiology, Mayo Clinic, Rochester, 200 First St. SW, Rochester, MN 55905.
William S HarmsenDepartment of Radiology, Mayo Clinic, Rochester, 200 First St. SW, Rochester, MN 55905; Department of Clinical Statistics, Mayo Clinic, Rochester, 200 First St. SW, Rochester, MN 55905.
Sanjay MisraDepartment of Radiology, Mayo Clinic, Rochester, 200 First St. SW, Rochester, MN 55905; Division of Vascular and Interventional Radiology, Mayo Clinic, Rochester, 200 First St. SW, Rochester, MN 55905. Electronic address: misra.sanjay@mayo.edu.

Funding

The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis GraftsR01HL098967 · NHLBI · MAYO CLINIC ROCHESTER · PI Sanjay Misra · 2010 to 2026
$10.4M
Regulatory gene-chemokine networks in the formation of hemodialysis AVF stenosisR01DK107870 · NIDDK · MAYO CLINIC ROCHESTER · PI KUMAR, RAJIV, MISRA, SANJAY · 2017 to 2019
$716k
Regulatory gene-chemokine networks in the formation of hemodialysis AVF stenosisR56DK107870 · NIDDK · MAYO CLINIC ROCHESTER · PI KUMAR, RAJIV, MISRA, SANJAY · 2020 to 2020
$103k
NHLBI NIH HHS R01 HL098967NIDDK NIH HHS R01 DK107870NIDDK NIH HHS R56 DK107870
6 · The paper itself

Abstract

purposeTo determine the impact of renal function trajectory, defined as the change in renal function over time before and after renal artery stent placement, on long-term risk for renal replacement therapy (RRT) and mortality. MATERIALS AND

methodsEstimated glomerular filtration rates (eGFRs) 6-12 months before renal artery stent placement, at the time of intervention, and 6-12 months after intervention were determined in 398 patients. The effect of eGFR change before and after renal artery stent placement was calculated. Cox proportional-hazards ratio was used to determine the risks for RRT and all-cause mortality.

resultsThe risk for RRT was significantly influenced by eGFR change from the time of intervention to follow-up at 6-12 month after treatment (P = .02). In addition, among patients with a postintervention eGFR ≤ 40 mL/min/1.73 m

conclusionsPostintervention eGFR trajectory improvement approaching 40 mL/min/1.73 m

Indexed as

Endovascular ProceduresGlomerular Filtration RateRenal Replacement TherapyAgedAged, 80 and overFemaleHumansKidneyMaleRecovery of FunctionRenal Artery ObstructionRetrospective StudiesRisk AssessmentRisk FactorsStentsTime Factors

Identifiers

PMID31530493
PMCPMC7069799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.